logo-loader
viewGenedrive PLC

Genedrive PLC looking to have its coronavirus test available in around eight weeks

Genedrive PLC's (LON:GDR) David Budd tells Proactive London's Andrew Scott a clinically validated high throughput format for its coronavirus test could be available in approximately eight weeks.

Its 96 SARS-COV-2 test can determine whether someone is infected with coronavirus.

As the test is freeze dried, it requires no refrigeration and is easier to transport

Quick facts: Genedrive PLC

Price: 164 GBX

AIM:GDR
Market: AIM
Market Cap: £73.59 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Genedrive PLC named herein, including the promotion by the Company of Genedrive PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Genedrive's David Budd details launch of its unique coronavirus test kits...

Genedrive PLC's (LON:GDR) David Budd recaps on its two coronavirus test kits. The first, which was CE marked last week and they're in the process of launching, is a high-throughput lab-based PCR test which assesses whether someone's got an active infection. The second is a point-of-care version...

1 day, 9 hours ago

2 min read